Imbruvica Shows Response in 2/3 of Steroid Dependent, Refractory cGVHD Patients in Phase II Study December 22, 2016Vol.39 No.11
Tagrisso Shows Superiority vs. Chemo in EGFR T790M Mutation-Positive Disease December 22, 2016Vol.39 No.11
Obama Signs Cures Act, Funding Biden’s Moonshot and Boosting NIH, NCI, FDA Budgets Over 10 Years December 16, 2016Vol.42 No.46By Matthew Bin Han Ong
Hackensack Cancer Center, MSKCC Form Business, Clinical Partnership in New Jersey December 16, 2016Vol.42 No.46By Paul Goldberg
Conversation with The Cancer LetterFree FDA: For Hospitals that Significantly Violated Federal Adverse Event Reporting Requirement, No Additional Action Necessary December 16, 2016Vol.42 No.46By Matthew Bin Han Ong
Free FDA Finds Lapses in Reporting of Patient Harm, Deaths Resulting from Medical Devices in Hospitals Nationwide December 16, 2016Vol.42 No.46By Matthew Bin Han Ong
Free Being an Acting Director, NCI’s Lowy Isn’t Required to Submit Resignation December 09, 2016Vol.42 No.45By Matthew Bin Han Ong
Free Senate Approves 21st Century Cures; CR Slates $300M for NCI and Moonshot December 09, 2016Vol.42 No.45By Matthew Bin Han Ong
Free DePinho Accepts Responsibility As MD Anderson’s Losses Grow December 09, 2016Vol.42 No.45By Paul Goldberg
